Cargando…
Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing
Genome editing has therapeutic potential for treating genetic diseases and cancer. However, the currently most practicable approaches rely on the generation of DNA double-strand breaks (DSBs), which can give rise to a poorly characterized spectrum of chromosome structural abnormalities. Here, using...
Autores principales: | Leibowitz, Mitchell L., Papathanasiou, Stamatis, Doerfler, Phillip A., Blaine, Logan J., Sun, Lili, Yao, Yu, Zhang, Cheng-Zhong, Weiss, Mitchell J., Pellman, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192433/ https://www.ncbi.nlm.nih.gov/pubmed/33846636 http://dx.doi.org/10.1038/s41588-021-00838-7 |
Ejemplares similares
-
Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing
por: Papathanasiou, Stamatis, et al.
Publicado: (2021) -
Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements
por: Zhang, Cheng-Zhong, et al.
Publicado: (2013) -
CRISPRthripsis: The Risk of CRISPR/Cas9-induced Chromothripsis in Gene Therapy
por: Amendola, Mario, et al.
Publicado: (2022) -
CRISPR/Cas9-induced DNA breaks trigger crossover, chromosomal loss, and chromothripsis-like rearrangements
por: Samach, Aviva, et al.
Publicado: (2023) -
CHROMOTHRIPSIS FROM DNA DAMAGE IN MICRONUCLEI
por: Zhang, Cheng-Zhong, et al.
Publicado: (2015)